Westford, MA, United States of America

Michael Batten

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Journey of Michael Batten in Biotechnology

Introduction

Michael Batten is a talented inventor based in Westford, Massachusetts, known for his significant contributions to the field of biotechnology. With a remarkable portfolio of eight patents, he has made strides in the production of steviol glycosides, which have applications in various industries, including food and pharmaceuticals.

Latest Patents

Two of his latest patents showcase his expertise in biosynthetic processes. The first patent, titled "Biosynthetic production of steviol glycosides and processes therefore," focuses on the production of steviol glycoside rebaudiosides D4, WB1, WB2, and the creation of rebaudioside M from Reb D4. This innovative approach has the potential to enhance the efficiency of glycoside production.

The second patent, "Biosynthetic production of steviol glycoside rebaudioside I via variant enzymes," details a methodology for producing rebaudioside I using variant UGT enzymes. This process involves transferring a glucosyl group from UDP-glucose to rebaudioside A, highlighting his innovative use of enzyme technology.

Career Highlights

Michael Batten is currently employed at Conagen Inc., a leading company in biotechnology. His work has positioned him as a notable figure in the industry, contributing to various advancements in natural product synthesis. His extensive knowledge and experience have helped lead to multiple patented technologies that promote sustainable and efficient practices in biochemical production.

Collaborations

Throughout his career, Michael has worked alongside talented colleagues, including Guohong Mao and Jacob Edward Vick. These collaborations reflect a strong team dynamic at Conagen Inc., where innovation thrives through collective expertise and shared objectives.

Conclusion

Michael Batten continues to be a driving force in the field of biotechnology. His dedication to developing innovative processes for the production of steviol glycosides demonstrates his commitment to enhancing sustainability in the industry. As he advances his research and development efforts, we look forward to seeing the future impacts of his inventions on our lives and the environment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…